Search Results 1591-1600 of 16679 for praluent side afects

  1. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Single Lung Transplantation - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  2. A Study To Evaluate The Long-term Safety And Tolerability Of Inhaled LIQ861(Treprostinil) In Pulmonary Arterial Hypertension Patients - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  3. Early Feasibility Study Of HyperQureTM RDN System, Laparoscopic Renal Denervation Therapy, In Patients With Resistant Hypertension - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  4. Mavacamten In Hypertrophic Cardiomyopathy Patients Referred For Septal Reduction Therapy - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  5. Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  6. Phase 1 Trial To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of Splicing Modulator H3B-8800 For Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, And Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  7. Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot) - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  8. The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  9. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

  10. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...